Strategies to insulate lentiviral vector-expressed transgenes.

piggyBac transposon plus insulators overcome epigenetic silencing to provide for stable signaling pathway reporter cell lines. PLoS One (2013) 0.90

Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science (2002) 17.71

'Green mice' as a source of ubiquitous green cells. FEBS Lett (1997) 17.06

Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell (2007) 16.66

The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92

pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res (1990) 12.75

Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature (2008) 12.01

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol (1987) 11.36

The protein CTCF is required for the enhancer blocking activity of vertebrate insulators. Cell (1999) 9.74

A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila. Cell (1993) 8.05

Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell (2008) 7.80

brahma: a regulator of Drosophila homeotic genes structurally related to the yeast transcriptional activator SNF2/SWI2. Cell (1992) 7.63

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol (1994) 6.60

CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus. Genes Dev (2006) 6.32

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol (1990) 5.81

We gather together: insulators and genome organization. Curr Opin Genet Dev (2007) 5.81

CTCF tethers an insulator to subnuclear sites, suggesting shared insulator mechanisms across species. Mol Cell (2004) 5.51

A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc Natl Acad Sci U S A (1986) 5.47

Versatile retroviral vectors for potential use in gene therapy. Gene Ther (1994) 5.33

Rapidly maturing variants of the Discosoma red fluorescent protein (DsRed). Nat Biotechnol (2002) 5.07

TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell (2007) 4.70

De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature (1982) 4.42

Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell (1986) 4.32

The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J (2001) 3.80

Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev (1998) 3.70

Modulation of enhancer-promoter interactions by insulators in the Drosophila embryo. Nature (1995) 3.61

Characterization of the chicken beta-globin insulator. Proc Natl Acad Sci U S A (1997) 3.57

Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities. Proc Natl Acad Sci U S A (2002) 3.46

Correction of sickle cell disease in transgenic mouse models by gene therapy. Science (2001) 3.25

Overcoming telomeric silencing: a trans-activator competes to establish gene expression in a cell cycle-dependent way. Genes Dev (1994) 3.20

Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity. Blood (2006) 3.07

Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell (1983) 3.06

CTCF-dependent chromatin insulator is linked to epigenetic remodeling. Mol Cell (2006) 2.93

Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther (2005) 2.81

Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog (2007) 2.75

Spreading of silent chromatin: inaction at a distance. Nat Rev Genet (2006) 2.64

The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci U S A (2002) 2.60

High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells (2003) 2.42

Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science (1992) 2.41

Loss of intervening sequences in genomic mouse alpha-globin DNA inserted in an infectious retrovirus vector. Nature (1982) 2.38

Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther (1999) 2.34

Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther (2006) 2.34

Chromatin insulators: regulatory mechanisms and epigenetic inheritance. Mol Cell (2008) 2.31

Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene (1990) 2.14

A functional enhancer suppresses silencing of a transgene and prevents its localization close to centrometric heterochromatin. Cell (1999) 2.12

Transcriptional enhancers act in cis to suppress position-effect variegation. Genes Dev (1996) 2.09

Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood (2007) 2.05

Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther (2000) 2.01

A chromatin insulator protects retrovirus vectors from chromosomal position effects. Proc Natl Acad Sci U S A (2000) 1.97

Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci U S A (1990) 1.96

Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J Virol (1987) 1.90

Transient gene expression by nonintegrating lentiviral vectors. Mol Ther (2006) 1.89

Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther (2001) 1.88

A system for Cre-regulated RNA interference in vivo. Proc Natl Acad Sci U S A (2008) 1.87

Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J (2000) 1.78

A stem cell-specific silencer in the primer-binding site of a retrovirus. Mol Cell Biol (1991) 1.72

Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc Natl Acad Sci U S A (1987) 1.68

Efficiency of recombination by Cre transient expression in embryonic stem cells: comparison of various promoters. J Biochem (1997) 1.68

In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat Genet (2006) 1.61

Position effect and related phenomena. Curr Opin Genet Dev (1992) 1.61

The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites. J Virol (2000) 1.60

The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. Virology (1989) 1.58

The immunoglobulin mu enhancer core establishes local factor access in nuclear chromatin independent of transcriptional stimulation. Genes Dev (1993) 1.57

Extended core sequences from the cHS4 insulator are necessary for protecting retroviral vectors from silencing position effects. Hum Gene Ther (2007) 1.55

Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol Ther (2004) 1.54

Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood (1997) 1.50

Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function. Blood (2000) 1.46

The degree of phenotypic correction of murine beta -thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Blood (2002) 1.45

Chromatin domain surrounding the human interferon-beta gene as defined by scaffold-attached regions. Biochemistry (1988) 1.42

Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood (2003) 1.40

Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol (1996) 1.39

Silent infection of murine embryonal carcinoma cells by Moloney murine leukemia virus. Virology (1980) 1.38

Hierarchical binding of DNA fragments derived from scaffold-attached regions: correlation of properties in vitro and function in vivo. Biochemistry (1990) 1.35

Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions. J Mol Biol (1997) 1.29

Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential. Stem Cells (2008) 1.29

Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy. Mol Cell Biol (2001) 1.28

Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions. Genes Dev (1999) 1.24

Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells. J Virol (1998) 1.21

Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors. Mol Ther (2002) 1.19

Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther (2001) 1.18

Genetic treatment of severe hemoglobinopathies: the combat against transgene variegation and transgene silencing. Semin Hematol (1998) 1.16

Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J Cell Biochem (1993) 1.16

Retrovirus silencer blocking by the cHS4 insulator is CTCF independent. Nucleic Acids Res (2003) 1.16

Identification of anti-repressor elements that confer high and stable protein production in mammalian cells. Nat Biotechnol (2003) 1.15

Association of the 5'HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits. Transgenic Res (1999) 1.12

The polyomavirus enhancer activates chromatin accessibility on integration into the HPRT gene. Mol Cell Biol (1992) 1.10

Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11. Proc Natl Acad Sci U S A (1996) 1.07

Overexpression of HOX11 leads to the immortalization of embryonic precursors with both primitive and definitive hematopoietic potential. Blood (1998) 1.02

Pluripotentiality and conditional transgene regulation in human embryonic stem cells expressing insulated tetracycline-ON transactivator. Stem Cells (2007) 1.00

Progress toward vector design for hematopoietic stem cell gene therapy. Curr Gene Ther (2001) 0.97

Scaffold/matrix-attached regions act upon transcription in a context-dependent manner. Biochemistry (1996) 0.96

Multiparameter flow cytometry of fluorescent protein reporters. Methods Mol Biol (2004) 0.95

Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood (1998) 0.94

Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector. J Virol (2000) 0.92

Beta-globin LCR and intron elements cooperate and direct spatial reorganization for gene therapy. PLoS Genet (2008) 0.91

Performance of genomic bordering elements at predefined genomic loci. Mol Cell Biol (2005) 0.90

Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T cells and macrophages. Hum Gene Ther (1999) 0.90

Overview of the HIV-1 Lentiviral Vector System. Curr Protoc Mol Biol (2002) 0.88

Generation of HIV-1-based lentiviral vector particles. Curr Protoc Mol Biol (2002) 0.88

Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum Gene Ther (2005) 3.49

High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells (2003) 2.42

HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells (2002) 1.94

Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol Ther (2007) 1.76

Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells? Mol Ther (2008) 1.47

Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. Blood (2003) 1.40

Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential. Stem Cells (2008) 1.29

Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling. Oncogene (2003) 1.28

Correction of murine hemophilia A by hematopoietic stem cell gene therapy. Mol Ther (2005) 1.25

Sustained phenotypic correction of hemophilia a mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells. Mol Ther (2004) 1.12

Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses. Blood (2002) 1.10

Role of the docking protein Gab2 in beta(1)-integrin signaling pathway-mediated hematopoietic cell adhesion and migration. Blood (2002) 1.00

Hematopoietic cell fate and the initiation of leukemic properties in primitive primary human cells are influenced by Ras activity and farnesyltransferase inhibition. Mol Cell Biol (2004) 1.00

G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia. Oncogene (2005) 0.98

Flow cytometry of fluorescent proteins. Methods (2012) 0.97

Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1. Am J Hematol (2013) 0.96

TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage. Br J Haematol (2006) 0.96

BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation. J Biol Chem (2003) 0.96

Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator. EMBO Rep (2010) 0.95

Multiparameter flow cytometry of fluorescent protein reporters. Methods Mol Biol (2004) 0.95

Bypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells. Stem Cells (2005) 0.95

Specific homeodomain-DNA interactions are required for HOX11-mediated transformation. Blood (2003) 0.93

Overexpression of rab7 enhances the kinetics of antigen processing and presentation with MHC class II molecules in B cells. Int Immunol (2002) 0.92

Development of improved factor VIII molecules and new gene transfer approaches for hemophilia A. Curr Gene Ther (2003) 0.90

Generation of HIV-1-based lentiviral vector particles. Curr Protoc Mol Biol (2002) 0.88

Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector. Mol Ther (2003) 0.88

Overview of the HIV-1 Lentiviral Vector System. Curr Protoc Mol Biol (2002) 0.88

Role of TLX1 in T-cell acute lymphoblastic leukaemia pathogenesis. Br J Haematol (2009) 0.88

Stable gammaretroviral vector expression during embryonic stem cell-derived in vitro hematopoietic development. Mol Ther (2006) 0.87

Immortalization of yolk sac-derived precursor cells. Blood (2002) 0.87

Resistance to fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation. J Vasc Res (2007) 0.85

Correction of murine hemophilia A following nonmyeloablative transplantation of hematopoietic stem cells engineered to encode an enhanced human factor VIII variant using a safety-augmented retroviral vector. Blood (2009) 0.85

TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells. Mol Cancer (2010) 0.85

Transcriptional activation by TLX1/HOX11 involves Gro/TLE corepressors. Biochem Biophys Res Commun (2009) 0.84

Reducing the genotoxic potential of retroviral vectors. Methods Mol Biol (2008) 0.84

Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice. Thromb Haemost (2011) 0.82

Genetic analysis of the ATG7 gene promoter in sporadic Parkinson's disease. Neurosci Lett (2013) 0.82

Analysis of violet-excited fluorochromes by flow cytometry using a violet laser diode. Cytometry A (2003) 0.81

Detection and enrichment of hematopoietic stem cells by side population phenotype. Methods Mol Biol (2004) 0.81

Integrative molecular and developmental biology of adult stem cells. Biol Cell (2003) 0.80

Retroviral transduction in fetal thymic organ culture. Methods Mol Med (2005) 0.80

A novel and functional variant within the ATG5 gene promoter in sporadic Parkinson's disease. Neurosci Lett (2013) 0.80

SCID repopulating cells derived from unmobilised adult human peripheral blood. Curr Med Res Opin (2004) 0.79

Specific pharmacological dimerization of KDR in lentivirally transduced human hematopoietic cells activates anti-apoptotic and proliferative mechanisms. FASEB J (2005) 0.79

Lentiviral fluorescent protein expression vectors for biotinylation proteomics. Methods Mol Biol (2011) 0.77

Hematopoietic immortalizing function of the NKL-subclass homeobox gene TLX1. Genes Chromosomes Cancer (2010) 0.77

Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation. Oncogene (2004) 0.77

Apoptotic role of IKK in T-ALL therapeutic response. Mol Cancer Res (2011) 0.76

Human immunodeficiency virus type 1-based vectors for gene delivery to human hematopoietic stem cells. Methods Mol Med (2003) 0.76

Somatic stem cell plasticity: to be or not to be. Stem Cells (2002) 0.75

Identification of a novel 21bp-insertion variant within the LC3B gene promoter in sporadic Parkinson's disease. Transl Res (2013) 0.75

Stem cell bouillabaisse-potpourri. Stem Cells (2002) 0.75

New feature: stem cells in the news. Stem Cells (2002) 0.75

The tao of hematopoietic stem cells: toward a unified theory of tissue regeneration. ScientificWorldJournal (2002) 0.75

Editorial retraction. Stem Cells (2006) 0.75

Advancing the fast-paced field of stem cell research: stem cells increases from 6 to 10 issues in its 23rd year of publication. Stem Cells (2005) 0.75